WO2006023444A2 - Anti-adhesion barrier - Google Patents

Anti-adhesion barrier Download PDF

Info

Publication number
WO2006023444A2
WO2006023444A2 PCT/US2005/028985 US2005028985W WO2006023444A2 WO 2006023444 A2 WO2006023444 A2 WO 2006023444A2 US 2005028985 W US2005028985 W US 2005028985W WO 2006023444 A2 WO2006023444 A2 WO 2006023444A2
Authority
WO
WIPO (PCT)
Prior art keywords
layer
tissue
hydroxyethyl methacrylate
biodegradable monomer
composite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/028985
Other languages
English (en)
French (fr)
Other versions
WO2006023444A3 (en
Inventor
Joshua B. Stopek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Covidien LP
Original Assignee
Tyco Healthcare Group LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tyco Healthcare Group LP filed Critical Tyco Healthcare Group LP
Priority to US11/660,577 priority Critical patent/US9034357B2/en
Priority to DE602005026015T priority patent/DE602005026015D1/de
Priority to JP2007527914A priority patent/JP4934036B2/ja
Priority to AU2005277591A priority patent/AU2005277591B2/en
Priority to CA2576422A priority patent/CA2576422C/en
Priority to EP05786516A priority patent/EP1778144B1/en
Publication of WO2006023444A2 publication Critical patent/WO2006023444A2/en
Publication of WO2006023444A3 publication Critical patent/WO2006023444A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/48—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00987—Apparatus or processes for manufacturing non-adhesive dressings or bandages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/01—Non-adhesive bandages or dressings
    • A61F13/01008—Non-adhesive bandages or dressings characterised by the material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/12—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L31/125—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L31/129—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix containing macromolecular fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/04—Surgical instruments, devices or methods for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/04—Surgical instruments, devices or methods for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06166—Sutures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/064—Surgical staples, i.e. penetrating the tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00089—Wound bandages
    • A61F2013/00157—Wound bandages for burns or skin transplants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00089—Wound bandages
    • A61F2013/00217—Wound bandages not adhering to the wound
    • A61F2013/00221—Wound bandages not adhering to the wound biodegradable, non-irritating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00089—Wound bandages
    • A61F2013/00217—Wound bandages not adhering to the wound
    • A61F2013/00221—Wound bandages not adhering to the wound biodegradable, non-irritating
    • A61F2013/00225—Wound bandages not adhering to the wound biodegradable, non-irritating with non-degradable reinforcing layer, net or mesh
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00089—Wound bandages
    • A61F2013/00217—Wound bandages not adhering to the wound
    • A61F2013/00229—Wound bandages not adhering to the wound with alginate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00089—Wound bandages
    • A61F2013/00357—Wound bandages implanted wound fillings or covers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00365—Plasters use
    • A61F2013/00387—Plasters use skin protection
    • A61F2013/00404—Plasters use skin protection against blisters or bed sores
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00365—Plasters use
    • A61F2013/00451—Plasters use for surgical sutures, e.g. butterfly type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00365—Plasters use
    • A61F2013/00519—Plasters use for treating burn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00902—Plasters containing means
    • A61F2013/0091—Plasters containing means with disinfecting or anaesthetics means, e.g. anti-mycrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00902—Plasters containing means
    • A61F2013/00927—Plasters containing means with biological activity, e.g. enzymes for debriding wounds or others, collagen or growth factors

Definitions

  • This disclosure relates to multi-layer devices for preventing tissue adhesion and promoting tissue growth.
  • Adhesions which may be formed include the adhesion of tissue to tissue or of tissue to bone. It has been known to separate adjacent internal bodily surfaces by interposing a mesh or film so that during tissue regeneration following surgery no contact exists between the surfaces.
  • One material which has been employed to prevent adhesions is an expanded polytetrafluoroethylene material known as Gore- Tex ® . This material, however, is not hemostatic and is non-degradable by the human body. Thus the implant remains in the body, and, if necessary, must be removed surgically following the healing process.
  • Another material is a mesh barrier of carboxymethylcellulose known as Interceed ® .
  • This material may not be applied in a blood-rich environment as under such circumstances the material quickly loses its barrier function.
  • Films formed from poly(ethyleneoxide) and polyethylene terephthalate have also been proposed as barrier materials to prevent surgical adhesions. It would be advantageous to provide a device for preventing the binding of tissue to tissue or of tissue to bone wherein the device prevents such binding while being sufficiently pliable as well as providing for growth of tissue, such as fibrous tissue, into the device.
  • Anti-adhesion devices in accordance with this disclosure have a first, film layer, and a second, gel layer.
  • the film side inhibits the formation of post-operative adhesions and scarring, and the gel side acts as a tissue scaffold and promotes wound healing, cellular infiltration, angiogenesis, etc.
  • the first layer acting as a barrier layer, has a water content of less than about 30%.
  • the second layer acting as a tissue growth promoter, has a water content of greater than about 40%.
  • FIG. 1 is a schematic perspective view of an anti-adhesion device in accordance with is disclosure.
  • FIG. 2 is a schematic flow sheet showing the steps of one exemplary process for making an anti-adhesion device in accordance with is disclosure.
  • an anti-adhesion device in accordance with this disclosure have a first, relatively smooth thin film layer 11, and a second gel layer 12.
  • the film side inhibits the formation of post-operative adhesions and scarring, and the gel side acts as a tissue scaffold and promotes wound healing, cellular infiltration, angiogenesis, etc.
  • the layers of the present anti-adhesion devices are made from a hydrophilic biomaterial.
  • suitable hydrophilic biomaterials include polymers formed from one or more of the following monomers: methacrylic acid, acrylic acid, n-vinyl pyrrolidone, potassium sulfopropylacrylate, potassium sulfopropylmethacrylate, acrylamide, dimethylacrylamide, 2-methacryloyloxyethyl phosphorylcholine, hydroxyethylmethacrylate or similar biocompatible water-soluble vinyl monomers.
  • at least one of the layers is formed from a solution containing hydroxyethylmethacrylate.
  • FIG. 2 schematically shows one exemplary preparation process.
  • the first, film side of the device can be formed by filling a mold 5 with a composition 6 containing the monomer(s) and, if desired or necessary, initiator, crosslinker, plasticizer and/or biological agent, and polymerizing the composition within the mold to form the film layer 11.
  • a composition 6 containing the monomer(s) and, if desired or necessary, initiator, crosslinker, plasticizer and/or biological agent,
  • the equilibrium water content (EWC), swelling, and mechanical properties of the film layer can be controlled by crosslink density (radiation conditions or crosslinker concentration).
  • the thickness of the film side can be controlled by the volume of the monomer composition polymerized in the mold. Suitable thickness for the film side can be is in the range of about 0.1 to about 5 mm.
  • the second, gel side can be prepared in situ upon the first, film side by exposing the previously prepared layer 11 to an aqueous solution 8 containing one or more of the above-mentioned monomers suitable for making hydrophilic polymers. This will cause the original film to swell. The swollen film, while resting in the second biodegradable monomer or comonomer solution, can be incubated to further enhance film swelling prior to polymerization.
  • the second monomer solution 7 is then polymerized in the presence of the swollen film 11 using low dose gamma radiation or conventional chemical initiated free radical polymerization or any other polymerization method within the purview of those skilled in the art to from the gel layer 12.
  • the resulting structure is a composite containing two-layers; namely, a first film layer 11 of relatively low water content and a second gel layer 12 having a relatively high water content.
  • the equilibrium water content (EWC), swelling, and mechanical properties of the gel side can be controlled by crosslink density (radiation conditions or DEOGMA concentration).
  • the thickness of the second, gel layer polymerized on top of the first, film layer is controlled by varying the volume of monomer solution. As the volume of the second monomer solution increases, the thickness of the gels layer increases as well. Typically, the thickness of the second, gel layer will be in the range of about 0.1 to about 5 mm. In the resulting composite, the gel layer is intimately associated with the relatively smooth thin film at the interface 13 between the two layers (see FIG. 1).
  • the gel may form an interpenetrating network (IPN) of gel monomer/comonomers within the attached thin film and/or covalent interactions, i.e. grafting of gel monomers to the thin film during in situ polymerization.
  • IPN interpenetrating network
  • the water content of the resulting composite increases as you move from the interface 13 towards the outer surface 14 of the second layer.
  • the size, structure, and morphology of the gel can be controlled through monomer selection and concentration, reaction conditions (i.e. gamma dose and dose rate), solvents (water, buffered saline, media, etc.), agents incorporated (proteins, drugs, AM agents, etc.), and other parameters.
  • the composites can also be lyophilized to produce a sponge-like morphology, on the second layer side, to assist in cell or tissue infiltration and wound healing, while retaining a smooth laminar surface on the film side.
  • the relatively smooth thin film side of the present anti- adhsion devices is made of poly-(hydroxyethyl methaerylate) (PHEMA)
  • PHEMA poly-(hydroxyethyl methaerylate)
  • such films can be synthesized using 60 Co gamma radiation, UV radiation, or conventional chemical initiated (AIBN, BPO, redox, etc.) free radical polymerization.
  • AIBN, BPO, redox, etc. conventional chemical initiated
  • the first side of the device can be prepared using radiation polymerization (600 mC source, 295 - 1180 rad/min, 0.05 - 1 Mrad) without the need of chemical initiator or crosslinker, and using the same washing/drying regiment.
  • radiation polymerization 600 mC source, 295 - 1180 rad/min, 0.05 - 1 Mrad
  • the present anti-adhesion devices can be any shape, and will normally be in the form of a sheet.
  • the devices can be made to size or prepared as a large sheet from which desired shapes are cut or punched.
  • the present anti-adhesion devices can advantageously be provided as six inch square sheets which can be cut to any desired size or shape by the surgeon prior to application to tissue.
  • the present anti-adhesion devices can also be surface modified following film formation.
  • a PHEMA anti-adhesion device can be surface modified with polymeric phospholipids for improved hemocompatibility and tissue interaction using gamma radiation grafting.
  • the surface of the anti-adhesion devices can be patterned or templated in the nano-meso-micro scale to accommodate preferential tissue interaction at the tissue/buttress interface.
  • Such architecture or patterns can prevent or minimize post-operative tissue adhesions and superfluous collagen deposition, but afford desired mechanical and biophysical support for wound healing.
  • composition from which each side of the anti-adhesion device is made may also contain one or more medically and/or surgically useful substances such as drugs, enzymes, growth factors, peptides, proteins, dyes, diagnostic agents or hemostasis agents or any other pharmaceutical used in the prevention of stenosis.
  • medically and/or surgically useful substances such as drugs, enzymes, growth factors, peptides, proteins, dyes, diagnostic agents or hemostasis agents or any other pharmaceutical used in the prevention of stenosis.
  • Non-limiting examples of suitable medically and/or surgically useful substances include: antimicrobials, antibiotics, anti-fungals, anti-virals, monoclonal antibodies, polyclonal antibodies, antimicrobial proteins/peptides (whole and fragments), enzymes, gene therapy, viral particles, chemotherapeutics, antiinflammatories, NSAIDS, steroids, telomerase inhibitors, growth factors (TGF family, interleukin superfamily, fibroblast derived GFs, macrophage derived GFs, etc.), extracellular matrix molecules (laminin, thrombospondin, collagen, fibronectin, synthetic ECM, etc.), cell adhesion molecules, polysaccharides (hyaluronic acid, carboxymethyl cellulose, alginate, sulfonated dextran, heparin sulfate, chitosan, etc.) and others.
  • TGF family interleukin superfamily
  • fibroblast derived GFs macrophage derived GFs
  • agents can be incorporated in situ into the composition used the make each side of the anti-adhesion device or post loaded onto either or each polymerized side of the anti-adhesion device using techniques within the purview of those skilled in the art.
  • the medically and/or surgically useful substances can be freely mixed or loaded, electronically or ionically bound, covalently immobilized, chelated, or encapsulated in particles, micelles, aggregates, or any nano-meso-micro solids of varied dimension, shape morphology and dispersion/suspension ability.
  • composition of the fist and second layers can be the same or different, depending on the composition of the monomer solutions employed in making each layer and the presence of any medically and/or surgically useful substances or optional ingredients.
  • Useful optional ingredients include, but are not limited too, plasticizers, emulsifiers, solvents, foaming agents, blowing agents, surfactants, radio-opaque markers, colors, dyes, fragrances, etc.. These optional ingredients, when present, may be present in an amount of up to about 5 wt. % of the first layer and/or the second layer.
  • the second layer may be coated with an adhesive such as, but not limited to, cellulose (such as carboxymethyl cellulose, or CMC, and hydroxypropyl methyl cellulose, or PIPMC); mucoadhesives, such as, but not limited to, mucin, mucopolysaccharides, polycarbophil, tragacanth, sodium alginate, gelatin, pectin, acacia, and providone; acrylates (such as polyacrylic acid and methyl methacrylate); polyoxyethylene glycol having a molecular weight of from about 100,000 to about 4,000,000; mixtures of zinc oxide and eugenol; a fibrin-glue layer; a chitosan layer; and glucosamine.
  • an adhesive such as, but not limited to, cellulose (such as carboxymethyl cellulose, or CMC, and hydroxypropyl methyl cellulose, or PIPMC); mucoadhesives, such as, but not limited to, mucin, mucopo
  • a fibrous reinforcing element such as a surgical grade mesh
  • Suitable fibrous reinforcing elements can be made from a biocompatible non-absorbable (i.e., permanent) material, such as, for example
  • Biocompatible materials can be woven, knit or non-woven.
  • Bio-absorbable materials include those fabricated from homopolymers, copolymers or blends obtained from one or more monomers selected from the group consisting of glycolide; glycolic acid, lactide, lactic acid, p-dioxanone, ⁇ -caprolactone and trimethylene carbonate.
  • Non-absorbable materials include those that are fabricated from such polymers as polyethylene, polypropylene, nylon, polyethylene terephthalate, polytetrafluoroethylene, polyvinylidene fluoride, and the like.
  • non-absorbable materials include and are not limited to stainless steel, titanium and the like.
  • the reinforcing element can be added to the mold prior to addition of the monomer solution used to form the film layer.
  • the reinforcing element can be placed on top of the film layer after it is formed, with the subsequent addition of the solution used to form the second, gel layer. Polymerization of the second solution will result in incorporation of the reinforcing element at or near the interface of the two layers.
  • the devices of the present disclosure may be employed as barriers between tissues or barriers between tissue and bone to prevent binding of tissue to tissue or of tissue to bone.
  • uses of the devices of the present disclosure include, but are not limited to, barriers between the internal female reproductive organs (e.g., uterus, Fallopian tubes, ovaries); barriers between the internal female reproductive organs and the peritoneum; barriers for used during laparoscopy; barriers between periodontal tissue; barriers between cartilages or between cartilage and bone; barriers between digestive organs; spinal barriers; barriers between digestive organs and peritoneum; barriers between the epicardium and surrounding structures such as the pericardium, mediastinal fat, pleura, and sternum; barriers between tendons and tendon sheaths, such as those in the wrist and ankle; bone fracture wraps; barriers between muscle tissue and bone; barriers between the esophagus and mediasternum; barriers between the gall bladder or pancreas and the peritoneum; and barriers for scrotal surgery, i.e., hern
  • the devices of the present disclosure may also be used for guided tissue regeneration.
  • the devices may be used to cover internal perforations, such as, for example, perforations in blood vessels, internal organs, the nasal septum, and the eardrum membrane, and may be used to reconstruct the abdominal wall, or to reinforce areas prone to, or showing scar formation, such as, for example, inguinal hernias.
  • the device therefore acts as a patch for covering the perforation until complete healing, followed by monomer absorption, is achieved.
  • the devices may be employed as a cover for bums, whereby the device acts as a patch until the burn is healed.
  • the devices of the present disclosure may be employed as a scaffolding to treat ulcers.
  • the second, growth promoting layer stimulates the proliferation of fibrous tissue, as a consequence of which, for example, in the case of ulcers, the wound bed becomes more optimal for the regeneration of skin.
  • the devices of the present disclosure may also be employed in redirect healing, whereby the devices are employed to protect nerves and organ coverings, and mucosa during the healing process, whereby the formation of fibrous tissue over such nerves, organs, and mucosa is prevented.
  • the devices may also be employed to prevent the formation of internal blood clots after surgery or traumatic injury.
  • the devices may also be employed in covering denuded epithelial surfaces or weakened areas such as damaged middle ear mucosa or other mucosal surfaces, thinned vascular walls, or surgically denuded areas, such as, for example, surgically denuded areas of the pelvis.
  • the devices may also be employed as anti-fibroblastic growth barriers, or as nerve coaptation wraps for connecting or repairing severed nerve ends or for repairing inflamed nerves. Since the resulting composites of the present disclosure are easily moldable, malleable and bendable, these devices may also be used with a wide variety of different medical devices, such as sutures, anchors, implants, scaffolds, staples, etc.
  • the present anti-adhesion devices can be sterilized and package using techniques within the purview of those skilled in the art. The method of sterilization should be chosen to preserve the efficacy of any medically and/or surgically useful substances contained in the device.
  • the device may be packaged in a pre-swollen or "wet" state which may lessen the devices shelf-life.
  • the device may be packaged in a "dry" or non-swollen state wherein the device could be pre-swollen prior to use or could swell in situ upon contact with natural bodily fluids. Such a packaging may lengthen the shelf- life of the device.
  • the present disclosure has related generally to specific embodiments of anti- adhesion devices and their use, it is to be understood, however, that the scope of the present disclosure is not to be limited to the specific embodiments described above.
  • the present layered devices can be formed into tubular structures.
  • the present devices are not limited to two layers, but rather more than two layers can be prepared, if desired using the presently described techniques. Therefore, the above description should not be construed as limiting, but merely as exemplifications of preferred embodiments. Those skilled in the art will envision other modifications within the scope and spirit of the present disclosure.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Composite Materials (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Manufacturing & Machinery (AREA)
  • Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
PCT/US2005/028985 2004-08-17 2005-08-16 Anti-adhesion barrier Ceased WO2006023444A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US11/660,577 US9034357B2 (en) 2004-08-17 2005-08-16 Anti-adhesion barrier
DE602005026015T DE602005026015D1 (de) 2004-08-17 2005-08-16 Antiadhäsionssperrschicht
JP2007527914A JP4934036B2 (ja) 2004-08-17 2005-08-16 抗癒着着バリア
AU2005277591A AU2005277591B2 (en) 2004-08-17 2005-08-16 Anti-adhesion barrier
CA2576422A CA2576422C (en) 2004-08-17 2005-08-16 Anti-adhesion barrier
EP05786516A EP1778144B1 (en) 2004-08-17 2005-08-16 Anti-adhesion barrier

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60222504P 2004-08-17 2004-08-17
US60/602,225 2004-08-17

Publications (2)

Publication Number Publication Date
WO2006023444A2 true WO2006023444A2 (en) 2006-03-02
WO2006023444A3 WO2006023444A3 (en) 2006-04-27

Family

ID=35968093

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/028985 Ceased WO2006023444A2 (en) 2004-08-17 2005-08-16 Anti-adhesion barrier

Country Status (8)

Country Link
US (1) US9034357B2 (https=)
EP (1) EP1778144B1 (https=)
JP (1) JP4934036B2 (https=)
AU (1) AU2005277591B2 (https=)
CA (1) CA2576422C (https=)
DE (1) DE602005026015D1 (https=)
ES (1) ES2356748T3 (https=)
WO (1) WO2006023444A2 (https=)

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7833284B2 (en) 2006-06-28 2010-11-16 The Cleveland Clinic Foundation Anti-adhesion membrane
US8690900B2 (en) 2008-07-21 2014-04-08 The Cleveland Clinic Foundation Apparatus and method for connecting two elongate body tissues
EP2419049A4 (en) * 2009-04-16 2014-12-10 Univ Keio TRANSPLANTATION DEVICE
US8932619B2 (en) * 2007-06-27 2015-01-13 Sofradim Production Dural repair material
US9445883B2 (en) 2011-12-29 2016-09-20 Sofradim Production Barbed prosthetic knit and hernia repair mesh made therefrom as well as process for making said prosthetic knit
US9499927B2 (en) 2012-09-25 2016-11-22 Sofradim Production Method for producing a prosthesis for reinforcing the abdominal wall
US9526603B2 (en) 2011-09-30 2016-12-27 Covidien Lp Reversible stiffening of light weight mesh
US9554887B2 (en) 2011-03-16 2017-01-31 Sofradim Production Prosthesis comprising a three-dimensional and openworked knit
US9622843B2 (en) 2011-07-13 2017-04-18 Sofradim Production Umbilical hernia prosthesis
US9839505B2 (en) 2012-09-25 2017-12-12 Sofradim Production Prosthesis comprising a mesh and a strengthening means
US9877820B2 (en) 2014-09-29 2018-01-30 Sofradim Production Textile-based prosthesis for treatment of inguinal hernia
US9932695B2 (en) 2014-12-05 2018-04-03 Sofradim Production Prosthetic porous knit
US9931198B2 (en) 2015-04-24 2018-04-03 Sofradim Production Prosthesis for supporting a breast structure
US9980802B2 (en) 2011-07-13 2018-05-29 Sofradim Production Umbilical hernia prosthesis
US10070948B2 (en) 2008-06-27 2018-09-11 Sofradim Production Biosynthetic implant for soft tissue repair
US10080639B2 (en) 2011-12-29 2018-09-25 Sofradim Production Prosthesis for inguinal hernia
US10159555B2 (en) 2012-09-28 2018-12-25 Sofradim Production Packaging for a hernia repair device
US10184032B2 (en) 2015-02-17 2019-01-22 Sofradim Production Method for preparing a chitosan-based matrix comprising a fiber reinforcement member
US10213283B2 (en) 2013-06-07 2019-02-26 Sofradim Production Textile-based prosthesis for laparoscopic surgery
US10327882B2 (en) 2014-09-29 2019-06-25 Sofradim Production Whale concept—folding mesh for TIPP procedure for inguinal hernia
US10363690B2 (en) 2012-08-02 2019-07-30 Sofradim Production Method for preparing a chitosan-based porous layer
US10368971B2 (en) 2007-12-03 2019-08-06 Sofradim Production Implant for parastomal hernia
US10405960B2 (en) 2013-06-07 2019-09-10 Sofradim Production Textile-based prothesis for laparoscopic surgery
US10549015B2 (en) 2014-09-24 2020-02-04 Sofradim Production Method for preparing an anti-adhesion barrier film
US10646321B2 (en) 2016-01-25 2020-05-12 Sofradim Production Prosthesis for hernia repair
US10682215B2 (en) 2016-10-21 2020-06-16 Sofradim Production Method for forming a mesh having a barbed suture attached thereto and the mesh thus obtained
US10743976B2 (en) 2015-06-19 2020-08-18 Sofradim Production Synthetic prosthesis comprising a knit and a non porous film and method for forming same
US10865505B2 (en) 2009-09-04 2020-12-15 Sofradim Production Gripping fabric coated with a bioresorbable impenetrable layer
US11471257B2 (en) 2018-11-16 2022-10-18 Sofradim Production Implants suitable for soft tissue repair
US12064330B2 (en) 2020-04-28 2024-08-20 Covidien Lp Implantable prothesis for minimally invasive hernia repair
US12496178B2 (en) 2017-05-02 2025-12-16 Sofradim Production Prosthesis for inguinal hernia repair

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090004455A1 (en) * 2007-06-27 2009-01-01 Philippe Gravagna Reinforced composite implant
US20090068250A1 (en) 2007-09-07 2009-03-12 Philippe Gravagna Bioresorbable and biocompatible compounds for surgical use
US9301826B2 (en) 2008-02-18 2016-04-05 Covidien Lp Lock bar spring and clip for implant deployment device
US9044235B2 (en) 2008-02-18 2015-06-02 Covidien Lp Magnetic clip for implant deployment device
US9398944B2 (en) 2008-02-18 2016-07-26 Covidien Lp Lock bar spring and clip for implant deployment device
US9034002B2 (en) 2008-02-18 2015-05-19 Covidien Lp Lock bar spring and clip for implant deployment device
US8317808B2 (en) 2008-02-18 2012-11-27 Covidien Lp Device and method for rolling and inserting a prosthetic patch into a body cavity
US9833240B2 (en) 2008-02-18 2017-12-05 Covidien Lp Lock bar spring and clip for implant deployment device
US9393002B2 (en) 2008-02-18 2016-07-19 Covidien Lp Clip for implant deployment device
WO2009104182A2 (en) 2008-02-18 2009-08-27 Polytouch Medical Ltd A device and method for deploying and attaching a patch to a biological tissue
US9393093B2 (en) 2008-02-18 2016-07-19 Covidien Lp Clip for implant deployment device
US8758373B2 (en) 2008-02-18 2014-06-24 Covidien Lp Means and method for reversibly connecting a patch to a patch deployment device
US8808314B2 (en) 2008-02-18 2014-08-19 Covidien Lp Device and method for deploying and attaching an implant to a biological tissue
WO2009108760A2 (en) 2008-02-26 2009-09-03 Board Of Regents, The University Of Texas System Dendritic macroporous hydrogels prepared by crystal templating
AU2009305958B9 (en) 2008-10-20 2013-07-11 Covidien Lp A device for attaching a patch to a biological tissue
US8748508B2 (en) 2008-12-29 2014-06-10 DePuy Synthes Products, LLC Method of forming and the resulting membrane composition for surgical site preservation
US9999424B2 (en) 2009-08-17 2018-06-19 Covidien Lp Means and method for reversibly connecting an implant to a deployment device
US8906045B2 (en) 2009-08-17 2014-12-09 Covidien Lp Articulating patch deployment device and method of use
US9649331B2 (en) * 2009-08-27 2017-05-16 Ara Medical Llc Sprayable polymers as adhesion barriers
US9402863B2 (en) * 2010-03-05 2016-08-02 Endosat Nv Methods and systems for conditioning in surgery
WO2012048283A1 (en) 2010-10-08 2012-04-12 Board Of Regents, The University Of Texas System One-step processing of hydrogels for mechanically robust and chemically desired features
JP6042815B2 (ja) 2010-10-08 2016-12-14 ザ ボード オブ リージェンツ オブ ザ ユニバーシティ オブ テキサス システム 生物医学的応用のためのアルギン酸塩及びヒアルロン酸を用いる抗癒着性バリア膜
US9861590B2 (en) * 2010-10-19 2018-01-09 Covidien Lp Self-supporting films for delivery of therapeutic agents
DE102011004239A1 (de) * 2011-02-16 2012-08-16 Gelita Ag Verwendung eines medizinischen Implantats als Adhäsionsbarriere
US9694106B2 (en) 2011-07-11 2017-07-04 Mimedx Group, Inc. Synthetic collagen threads for cosmetic uses including skin wrinkle treatments and associated methods
CA2847615A1 (en) 2011-09-30 2013-04-04 Sofradim Production Multilayer implants for delivery of therapeutic agents
FR2995788B1 (fr) 2012-09-25 2014-09-26 Sofradim Production Patch hemostatique et procede de preparation
US11565027B2 (en) 2012-12-11 2023-01-31 Board Of Regents, The University Of Texas System Hydrogel membrane for adhesion prevention
EP2931327B1 (en) 2012-12-11 2019-02-13 Board Of Regents, The University Of Texas System Hydrogel membrane for adhesion prevention
DE102013004574A1 (de) * 2013-03-11 2014-09-11 Johnson & Johnson Medical Gmbh Chirurgisches Implantat
US9907882B2 (en) 2014-04-18 2018-03-06 Warsaw Orthopedic, Inc. Demineralized bone matrix with improved osteoinductivity
CN105194739A (zh) * 2015-10-30 2015-12-30 广州市电纺生物科技有限公司 一种双层结构的防粘连膜及其制备方法
WO2018165327A1 (en) 2017-03-08 2018-09-13 Alafair Biosciences, Inc. Hydrogel medium for the storage and preservation of tissue
CA3171384A1 (en) 2020-02-28 2021-09-02 Texas Medical Center Sprayable stimuli-responsive micro-hydrogels for adhesion prevention and enhanced tissue healing
CN114569803B (zh) * 2020-11-30 2023-10-03 财团法人工业技术研究院 抗卷曲薄膜
CN114948033A (zh) * 2022-05-10 2022-08-30 华东师范大学 皮肤吻合器
DE102023119400A1 (de) 2023-07-21 2025-01-23 Leibniz-Institut Für Polymerforschung Dresden E.V. Haftschicht für Materialverbunde

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993021858A1 (en) 1992-04-24 1993-11-11 Osteotech, Inc. Devices for preventing tissue adhesion
WO1997035533A1 (en) 1996-03-25 1997-10-02 Enrico Nicolo Surgical mesh prosthetic material and methods of use

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954593A (en) * 1989-08-18 1990-09-04 Gaf Chemical Corporation Furanone/vinyl ether copolymers
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
JP2896216B2 (ja) * 1990-09-19 1999-05-31 テルモ株式会社 創傷被覆材
US5226902A (en) * 1991-07-30 1993-07-13 University Of Utah Pulsatile drug delivery device using stimuli sensitive hydrogel
US6403655B1 (en) * 1995-03-06 2002-06-11 Ethicon, Inc. Method of preventing adhesions with absorbable polyoxaesters
US5914182A (en) * 1996-06-03 1999-06-22 Gore Hybrid Technologies, Inc. Materials and methods for the immobilization of bioactive species onto polymeric substrates
AUPP297898A0 (en) * 1998-04-16 1998-05-07 Unisearch Limited Production of furanones
US7029700B2 (en) * 2000-01-14 2006-04-18 Brown University Research Foundation Micronized freeze-dried particles
US20040018228A1 (en) * 2000-11-06 2004-01-29 Afmedica, Inc. Compositions and methods for reducing scar tissue formation
ATE359094T1 (de) * 2001-02-14 2007-05-15 Genzyme Corp Biokompatibles vlies für hämostase und gewebeaufbau
DE60208454T2 (de) * 2001-03-02 2006-09-07 Nof Corp. Polyalkylenoxid-modifizierte Phospholipide und Verfahren zu ihrer Herstellung
US6939554B2 (en) * 2002-02-05 2005-09-06 Michigan Biotechnology Institute Antimicrobial polymer
EP1498420B1 (en) 2002-03-29 2017-02-01 Nof Corporation Phospholipid derivative
US20050208093A1 (en) * 2004-03-22 2005-09-22 Thierry Glauser Phosphoryl choline coating compositions
CA2526541C (en) * 2004-12-01 2013-09-03 Tyco Healthcare Group Lp Novel biomaterial drug delivery and surface modification compositions
US20060129225A1 (en) * 2004-12-15 2006-06-15 Kopia Gregory A Device for the delivery of a cardioprotective agent to ischemic reperfused myocardium
JP5167251B2 (ja) 2006-05-15 2013-03-21 タイコ ヘルスケア グループ リミテッド パートナーシップ 抗菌コーティング
JP2009545642A (ja) * 2006-08-03 2009-12-24 チバ ホールディング インコーポレーテッド 表面の湿潤性を改良するための組成物

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993021858A1 (en) 1992-04-24 1993-11-11 Osteotech, Inc. Devices for preventing tissue adhesion
WO1997035533A1 (en) 1996-03-25 1997-10-02 Enrico Nicolo Surgical mesh prosthetic material and methods of use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1778144A4

Cited By (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7833284B2 (en) 2006-06-28 2010-11-16 The Cleveland Clinic Foundation Anti-adhesion membrane
US8932619B2 (en) * 2007-06-27 2015-01-13 Sofradim Production Dural repair material
US10368971B2 (en) 2007-12-03 2019-08-06 Sofradim Production Implant for parastomal hernia
US10070948B2 (en) 2008-06-27 2018-09-11 Sofradim Production Biosynthetic implant for soft tissue repair
US8690900B2 (en) 2008-07-21 2014-04-08 The Cleveland Clinic Foundation Apparatus and method for connecting two elongate body tissues
EP2419049A4 (en) * 2009-04-16 2014-12-10 Univ Keio TRANSPLANTATION DEVICE
US11970798B2 (en) 2009-09-04 2024-04-30 Sofradim Production Gripping fabric coated with a bioresorbable impenetrable layer
US10865505B2 (en) 2009-09-04 2020-12-15 Sofradim Production Gripping fabric coated with a bioresorbable impenetrable layer
US11612472B2 (en) 2011-03-16 2023-03-28 Sofradim Production Prosthesis comprising a three-dimensional and openworked knit
US9554887B2 (en) 2011-03-16 2017-01-31 Sofradim Production Prosthesis comprising a three-dimensional and openworked knit
US12258689B2 (en) 2011-03-16 2025-03-25 Sofradim Production Prosthesis comprising a three-dimensional and openworked knit
US10472750B2 (en) 2011-03-16 2019-11-12 Sofradim Production Prosthesis comprising a three-dimensional and openworked knit
US11039912B2 (en) 2011-07-13 2021-06-22 Sofradim Production Umbilical hernia prosthesis
US9980802B2 (en) 2011-07-13 2018-05-29 Sofradim Production Umbilical hernia prosthesis
US10709538B2 (en) 2011-07-13 2020-07-14 Sofradim Production Umbilical hernia prosthesis
US9622843B2 (en) 2011-07-13 2017-04-18 Sofradim Production Umbilical hernia prosthesis
US12329626B2 (en) 2011-07-13 2025-06-17 Sofradim Production Umbilical hernia prosthesis
US11903807B2 (en) 2011-07-13 2024-02-20 Sofradim Production Umbilical hernia prosthesis
US9526603B2 (en) 2011-09-30 2016-12-27 Covidien Lp Reversible stiffening of light weight mesh
US11925543B2 (en) 2011-12-29 2024-03-12 Sofradim Production Barbed prosthetic knit and hernia repair mesh made therefrom as well as process for making said prosthetic knit
US10342652B2 (en) 2011-12-29 2019-07-09 Sofradim Production Barbed prosthetic knit and hernia repair mesh made therefrom as well as process for making said prosthetic knit
US11266489B2 (en) 2011-12-29 2022-03-08 Sofradim Production Barbed prosthetic knit and hernia repair mesh made therefrom as well as process for making said prosthetic knit
US11471256B2 (en) 2011-12-29 2022-10-18 Sofradim Production Prosthesis for inguinal hernia
US9445883B2 (en) 2011-12-29 2016-09-20 Sofradim Production Barbed prosthetic knit and hernia repair mesh made therefrom as well as process for making said prosthetic knit
US10080639B2 (en) 2011-12-29 2018-09-25 Sofradim Production Prosthesis for inguinal hernia
US12419733B2 (en) 2011-12-29 2025-09-23 Sofradim Production Prosthesis for inguinal hernia
US10363690B2 (en) 2012-08-02 2019-07-30 Sofradim Production Method for preparing a chitosan-based porous layer
US9499927B2 (en) 2012-09-25 2016-11-22 Sofradim Production Method for producing a prosthesis for reinforcing the abdominal wall
US9839505B2 (en) 2012-09-25 2017-12-12 Sofradim Production Prosthesis comprising a mesh and a strengthening means
US10159555B2 (en) 2012-09-28 2018-12-25 Sofradim Production Packaging for a hernia repair device
US10405960B2 (en) 2013-06-07 2019-09-10 Sofradim Production Textile-based prothesis for laparoscopic surgery
US11622845B2 (en) 2013-06-07 2023-04-11 Sofradim Production Textile-based prothesis for laparoscopic surgery
US10213283B2 (en) 2013-06-07 2019-02-26 Sofradim Production Textile-based prosthesis for laparoscopic surgery
US12059338B2 (en) 2013-06-07 2024-08-13 Sofradim Production Textile-based prothesis for laparoscopic surgery
US11304790B2 (en) 2013-06-07 2022-04-19 Sofradim Production Textile-based prothesis for laparoscopic surgery
US12070534B2 (en) 2014-09-24 2024-08-27 Sofradim Production Method for preparing an anti-adhesion barrier film
US10549015B2 (en) 2014-09-24 2020-02-04 Sofradim Production Method for preparing an anti-adhesion barrier film
US11291536B2 (en) 2014-09-29 2022-04-05 Sofradim Production Whale concept-folding mesh for TIPP procedure for inguinal hernia
US10327882B2 (en) 2014-09-29 2019-06-25 Sofradim Production Whale concept—folding mesh for TIPP procedure for inguinal hernia
US10653508B2 (en) 2014-09-29 2020-05-19 Sofradim Production Textile-based prosthesis for treatment of inguinal hernia
US11589974B2 (en) 2014-09-29 2023-02-28 Sofradim Production Textile-based prosthesis for treatment of inguinal hernia
US9877820B2 (en) 2014-09-29 2018-01-30 Sofradim Production Textile-based prosthesis for treatment of inguinal hernia
US11359313B2 (en) 2014-12-05 2022-06-14 Sofradim Production Prosthetic porous knit
US9932695B2 (en) 2014-12-05 2018-04-03 Sofradim Production Prosthetic porous knit
US12091788B2 (en) 2014-12-05 2024-09-17 Sofradim Production Prosthetic porous knit
US12392064B2 (en) 2014-12-05 2025-08-19 Sofradim Production Prosthetic porous knit
US11713526B2 (en) 2014-12-05 2023-08-01 Sofradim Production Prosthetic porous knit
US10815345B2 (en) 2015-02-17 2020-10-27 Sofradim Production Method for preparing a chitosan-based matrix comprising a fiber reinforcement member
US10184032B2 (en) 2015-02-17 2019-01-22 Sofradim Production Method for preparing a chitosan-based matrix comprising a fiber reinforcement member
US12161547B2 (en) 2015-04-24 2024-12-10 Sofradim Production Prosthesis for supporting a breast structure
US9931198B2 (en) 2015-04-24 2018-04-03 Sofradim Production Prosthesis for supporting a breast structure
US11826242B2 (en) 2015-06-19 2023-11-28 Sofradim Production Synthetic prosthesis comprising a knit and a non porous film and method for forming same
US12257137B2 (en) 2015-06-19 2025-03-25 Sofradim Production Synthetic prosthesis comprising a knit and a non porous film and method for forming same
US10743976B2 (en) 2015-06-19 2020-08-18 Sofradim Production Synthetic prosthesis comprising a knit and a non porous film and method for forming same
US10646321B2 (en) 2016-01-25 2020-05-12 Sofradim Production Prosthesis for hernia repair
US11389282B2 (en) 2016-01-25 2022-07-19 Sofradim Production Prosthesis for hernia repair
US10682215B2 (en) 2016-10-21 2020-06-16 Sofradim Production Method for forming a mesh having a barbed suture attached thereto and the mesh thus obtained
US11696819B2 (en) 2016-10-21 2023-07-11 Sofradim Production Method for forming a mesh having a barbed suture attached thereto and the mesh thus obtained
US12496178B2 (en) 2017-05-02 2025-12-16 Sofradim Production Prosthesis for inguinal hernia repair
US11471257B2 (en) 2018-11-16 2022-10-18 Sofradim Production Implants suitable for soft tissue repair
US12605242B2 (en) 2018-11-16 2026-04-21 Sofradim Production Methods of forming implants suitable for soft tissue repair
US12064330B2 (en) 2020-04-28 2024-08-20 Covidien Lp Implantable prothesis for minimally invasive hernia repair

Also Published As

Publication number Publication date
EP1778144B1 (en) 2011-01-19
CA2576422A1 (en) 2006-03-02
WO2006023444A3 (en) 2006-04-27
JP2008509788A (ja) 2008-04-03
AU2005277591A1 (en) 2006-03-02
JP4934036B2 (ja) 2012-05-16
EP1778144A2 (en) 2007-05-02
EP1778144A4 (en) 2009-08-19
AU2005277591B2 (en) 2011-07-14
US20070280990A1 (en) 2007-12-06
DE602005026015D1 (de) 2011-03-03
US9034357B2 (en) 2015-05-19
CA2576422C (en) 2013-10-29
ES2356748T3 (es) 2011-04-12

Similar Documents

Publication Publication Date Title
US9034357B2 (en) Anti-adhesion barrier
JP3233326U (ja) 修復領域が安定する軟組織修復用複合材料
JP4275204B2 (ja) 酸化セルロ−ス多層フィルムを形成する方法及び手術癒着を防止するための方法
CA2691413C (en) Reinforced composite implant
JP4840783B2 (ja) 水膨潤性コポリマーおよびそれから作製される物品およびコーティング
JP4977600B2 (ja) 外科手術用のメッシュ状インプラント
JP2004512314A (ja) 局所的な治療に用いられる粘着性の水和可能なマトリックス
CA2334664A1 (en) Collagen material and its production process
US11622892B2 (en) Methods of making bioactive collagen wound care dressings
US9796769B2 (en) Methods of making bioactive collagen medical scaffolds such as for wound care dressings, hernia repair prosthetics, and surgical incision closure members
US20130226313A1 (en) Bioactive Scaffold for Therapeutic and Adhesion Prevention Applications
MX2007007744A (es) Barreras, sistemas, y metodos antimicrobianos formados a partir de estructuras polimericas hidrofilicas tales como quitosana.
KR101436615B1 (ko) 유착방지기능을 갖는 수술용 메쉬 복합체 및 이의 제조 방법
MXPA97004970A (en) Mixed biorreabsorbible material of oxidized cellulose for the prevention of post-quirurgi adherences

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2007527914

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2005277591

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2576422

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 11660577

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2005786516

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2005277591

Country of ref document: AU

Date of ref document: 20050816

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2005277591

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2005786516

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 11660577

Country of ref document: US